Trial Profile

A first in human clinical trial of ZE74-0282

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 30 Dec 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ZE 74 0282 (Primary)
Indications Myeloproliferative disorders; Polycythaemia vera
Focus Adverse reactions; First in man

Most Recent Events

17 Dec 2025 According to an Eilean Therapeutics media release, an IND application has been submitted to support first-in-human clinical studies of ZE74-0282. Enrollment in this study is planned to begin in the first quarter of 2026.
09 Dec 2025 New trial record
06 Nov 2025 According to an Eilean Therapeutics media release, the company plans to initiate December 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com